首页 > 最新文献

Journal of Gastrointestinal Surgery最新文献

英文 中文
A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy 一项IV期胃癌转化手术的单中心回顾性研究:与基于ci的化疗相关。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-19 DOI: 10.1016/j.gassur.2025.102301
Yuki Ushimaru, Takeshi Omori, Kazuyoshi Yamamoto, Kei Yamamoto, Yasunori Masuike, Yoshitomo Yanagimoto, Norihiro Matsuura, Takahito Sugase, Takashi Kanemura, Ryota Mori, Masatoshi Kitakaze, Masahiko Kubo, Yasunari Fukuda, Hisateru Komatsu, Masaaki Miyo, Toshinori Sueda, Yoshinori Kagawa, Kunihito Gotoh, Shogo Kobayashi, Hiroshi Miyata

Background

Stage IV gastric cancer remains challenging to treat despite recent advances in systemic therapy. Among patients with favorable responses to chemotherapy, conversion surgery aiming for R0 resection has shown promise in improving survival. Immune checkpoint inhibitors (ICIs) have become a key component of systemic treatment, but their prognostic impact in the setting of conversion surgery remains unclear.

Methods

This retrospective single-center study included 98 patients with gastric cancer who received platinum-based doublet chemotherapy followed by minimally invasive surgery. Patients were stratified into ICI (n = 41) and non-ICI groups (n = 57). Perioperative outcomes, progression-free survival (PFS), and overall survival (OS) were evaluated using Kaplan–Meier analysis and Cox regression models.

Results

The median operative time was 345 min, and the median blood loss was 5 mL. R0 resection was achieved in 79.6% of cases, and the median hospital stay was 7 days. Clavien–Dindo grade ≥ II complications occurred in 12.2% of patients. ICI-treated patients had significantly longer PFS (hazard ratio [HR], 0.418; P =.0008) and OS (HR, 0.437; P =.024). R0 resection was independently associated with improved PFS (HR, 0.179; P <.0001) and OS (HR, 0.231; P <.0001). Multivariate analysis identified pathological N status, R0 resection, and ICI use as independent predictors of PFS.

Conclusion

Among patients who underwent conversion surgery in this real-world cohort, those treated with ICI-based chemotherapy demonstrated more favorable long-term outcomes than those treated with chemotherapy alone. Although our findings do not demonstrate a causal relationship of ICI therapy on resectability, they suggest that ICI-based chemotherapy may be associated with improved survival in appropriately selected patients with human epidermal growth factor receptor 2–negative stage IV gastric cancer. Prospective studies are warranted to clarify optimal indications and perioperative strategies for integrating ICI-based regimens into conversion treatment.
背景:尽管最近在全身治疗方面取得了进展,IV期胃癌的治疗仍然具有挑战性。在对化疗反应良好的患者中,以R0切除为目标的转换手术已显示出改善生存的希望。免疫检查点抑制剂(ICIs)已成为全身治疗的关键组成部分,但其在转换手术中的预后影响尚不清楚。方法:本研究为回顾性单中心研究,纳入98例接受以铂为基础的双重化疗伴微创手术的胃癌患者。将患者分为ICI组(n=41)和非ICI组(n=57)。采用Kaplan-Meier分析和Cox回归模型评估围手术期结局、无进展生存期(PFS)和总生存期(OS)。结果:中位手术时间345min,中位失血量5ml。R0切除率为79.6%,中位住院时间为7天。12.2%的患者出现≥Clavien-Dindo II级并发症。ci治疗组PFS (HR 0.418, P=0.0008)和OS (HR 0.437, P=0.024)均显著延长。R0切除与PFS的改善独立相关(HR 0.179, p)。结论:在这个现实世界队列中接受转换手术的患者中,接受基于ci的化疗的患者比单独化疗的患者表现出更有利的长期预后。虽然我们的研究结果没有证明ICI治疗与可切除性之间的因果关系,但它们表明,在适当选择的her2阴性IV期胃癌患者中,ICI化疗可能与生存率的提高有关。前瞻性研究是必要的,以明确最佳适应症和围手术期策略,以整合基于ci的方案转化治疗。
{"title":"A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy","authors":"Yuki Ushimaru,&nbsp;Takeshi Omori,&nbsp;Kazuyoshi Yamamoto,&nbsp;Kei Yamamoto,&nbsp;Yasunori Masuike,&nbsp;Yoshitomo Yanagimoto,&nbsp;Norihiro Matsuura,&nbsp;Takahito Sugase,&nbsp;Takashi Kanemura,&nbsp;Ryota Mori,&nbsp;Masatoshi Kitakaze,&nbsp;Masahiko Kubo,&nbsp;Yasunari Fukuda,&nbsp;Hisateru Komatsu,&nbsp;Masaaki Miyo,&nbsp;Toshinori Sueda,&nbsp;Yoshinori Kagawa,&nbsp;Kunihito Gotoh,&nbsp;Shogo Kobayashi,&nbsp;Hiroshi Miyata","doi":"10.1016/j.gassur.2025.102301","DOIUrl":"10.1016/j.gassur.2025.102301","url":null,"abstract":"<div><h3>Background</h3><div>Stage IV gastric cancer remains challenging to treat despite recent advances in systemic therapy. Among patients with favorable responses to chemotherapy, conversion surgery aiming for R0 resection has shown promise in improving survival. Immune checkpoint inhibitors (ICIs) have become a key component of systemic treatment, but their prognostic impact in the setting of conversion surgery remains unclear.</div></div><div><h3>Methods</h3><div>This retrospective single-center study included 98 patients with gastric cancer who received platinum-based doublet chemotherapy followed by minimally invasive surgery. Patients were stratified into ICI (n = 41) and non-ICI groups (n = 57). Perioperative outcomes, progression-free survival (PFS), and overall survival (OS) were evaluated using Kaplan–Meier analysis and Cox regression models.</div></div><div><h3>Results</h3><div>The median operative time was 345 min, and the median blood loss was 5 mL. R0 resection was achieved in 79.6% of cases, and the median hospital stay was 7 days. Clavien–Dindo grade ≥ II complications occurred in 12.2% of patients. ICI-treated patients had significantly longer PFS (hazard ratio [HR], 0.418; <em>P</em> =.0008) and OS (HR, 0.437; <em>P</em> =.024). R0 resection was independently associated with improved PFS (HR, 0.179; <em>P</em> &lt;.0001) and OS (HR, 0.231; <em>P</em> &lt;.0001). Multivariate analysis identified pathological N status, R0 resection, and ICI use as independent predictors of PFS.</div></div><div><h3>Conclusion</h3><div>Among patients who underwent conversion surgery in this real-world cohort, those treated with ICI-based chemotherapy demonstrated more favorable long-term outcomes than those treated with chemotherapy alone. Although our findings do not demonstrate a causal relationship of ICI therapy on resectability, they suggest that ICI-based chemotherapy may be associated with improved survival in appropriately selected patients with human epidermal growth factor receptor 2–negative stage IV gastric cancer. Prospective studies are warranted to clarify optimal indications and perioperative strategies for integrating ICI-based regimens into conversion treatment.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102301"},"PeriodicalIF":2.4,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of immunotherapy in the treatment of tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors: a systematic review and meta-analysis 免疫疗法治疗tki难治性胃肠道间质瘤的疗效:系统回顾和荟萃分析。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-18 DOI: 10.1016/j.gassur.2025.102307
YuLong Zhang , XianHao Xiao , JiaYing Tan, Liang Shan, He Song

Background

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. The advent of tyrosine kinase inhibitors (TKIs), such as imatinib, has significantly improved clinical outcomes in patients with GISTs by delaying metastasis and prolonging survival. However, most patients eventually develop resistance to TKIs, limiting long-term disease control. Immunotherapy has demonstrated durable responses in various solid tumors and has emerged as a potential treatment strategy for TKI-refractory GISTs. This study aimed to systematically evaluate the efficacy and safety of immunotherapy in patients with advanced or recurrent GIST, particularly those who have failed previous TKI therapy, to inform future clinical decision-making and research directions.

Methods

A systematic literature search of PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov was conducted for studies published before June 23, 2025. The inclusion criteria focused on immunotherapy interventions in patients with histologically confirmed GIST. Study selection, data extraction, and risk of bias assessments were performed independently by 2 reviewers according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Joanna Briggs Institute checklist was used for quality appraisal. Random-effects models were used to pool estimates of clinical benefit rate (CBR), objective response rate (ORR), progression-free survival (PFS), and overall survival (OS). Generalized linear mixed models (GLMM) were used to account for cohorts with extreme values. This review protocol was registered with the International Registry of Systematic Reviews (registration number: CRD42024496866).

Results

A total of 9 studies involving 169 patients were included. The pooled CBR was 41.69% (95% CI, 26.99%–58.03%), and the ORR was 16.49% (95% CI, 6.25%–36.91%), both with moderate to high heterogeneity. GLMM adjustments, which incorporated additional extreme value cohorts, yielded a corrected CBR of 46.39% (95% CI, 28.85%–64.88%) and ORR of 13.23% (95% CI, 4.21%–34.56%). The pooled median PFS across 7 cohorts was 6.11 months (95% CI, 2.63–9.59), and the OS, which was calculated using 2 models, ranged from 15.53 to 17.01 months, depending on the data imputation strategy.

Conclusion

This meta-analysis suggests that immunotherapy provides modest yet clinically meaningful efficacy in patients with advanced or treatment-refractory GIST. Despite considerable heterogeneity among studies, the observed trends in response and survival outcomes support immunotherapy as a viable treatment option. Further large-scale, biomarker-driven clinical trials are warranted to validate these findings and guide personalized therapeutic strategies.
背景:胃肠道间质瘤(gist)是最常见的胃肠道间质肿瘤。酪氨酸激酶抑制剂(TKIs)的出现,如伊马替尼,通过延缓转移和延长生存期,显著改善了GIST患者的临床结果。然而,大多数患者最终对tki产生耐药性,限制了疾病的长期控制。免疫疗法在多种实体瘤中表现出持久的反应,并已成为tki难治性gist的潜在治疗策略。目的:本研究旨在系统评价免疫治疗对晚期或复发GIST患者的疗效和安全性,特别是那些先前TKI治疗失败的患者,为未来的临床决策和研究方向提供信息。方法:我们对PubMed、Embase、Web of Science、Cochrane Library和ClinicalTrials.gov进行了系统的文献检索,检索2025年6月23日之前发表的研究。纳入标准侧重于组织学证实的GIST患者的免疫治疗干预。研究选择、数据提取和偏倚风险评估由两位审稿人根据PRISMA指南独立完成。乔安娜布里格斯研究所(JBI)检查表用于质量评估。采用随机效应模型对临床获益率(CBR)、客观缓解率(ORR)、无进展生存期(PFS)和总生存期(OS)进行汇总估计。应用广义线性混合模型(GLMM)来解释具有极值的队列。该审查方案已在PROSPERO注册(CRD42024496866)。结果:纳入9项研究,共169例患者。合并CBR为41.69% (95% CI: 26.99%-58.03%), ORR为16.49% (95% CI: 6.25%-36.91%),均具有中等至高度异质性。GLMM调整纳入了额外的极值队列,校正后的CBR为46.39% (95% CI: 28.85%-64.88%), ORR为13.23% (95% CI: 4.21%-34.56%)。7个队列的合并中位PFS为6.11个月(95% CI: 2.63-9.59),使用两种模型计算的OS范围为15.53个月至17.01个月,具体取决于数据输入策略。结论:这项荟萃分析表明,免疫疗法对晚期或难治性GIST患者提供了适度但有临床意义的疗效。尽管研究之间存在相当大的异质性,但观察到的反应和生存结果趋势支持免疫治疗作为一种可行的治疗选择。进一步的大规模,生物标志物驱动的临床试验是必要的,以验证这些发现和指导个性化的治疗策略。
{"title":"The efficacy of immunotherapy in the treatment of tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors: a systematic review and meta-analysis","authors":"YuLong Zhang ,&nbsp;XianHao Xiao ,&nbsp;JiaYing Tan,&nbsp;Liang Shan,&nbsp;He Song","doi":"10.1016/j.gassur.2025.102307","DOIUrl":"10.1016/j.gassur.2025.102307","url":null,"abstract":"<div><h3>Background</h3><div>Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. The advent of tyrosine kinase inhibitors (TKIs), such as imatinib, has significantly improved clinical outcomes in patients with GISTs by delaying metastasis and prolonging survival. However, most patients eventually develop resistance to TKIs, limiting long-term disease control. Immunotherapy has demonstrated durable responses in various solid tumors and has emerged as a potential treatment strategy for TKI-refractory GISTs. This study aimed to systematically evaluate the efficacy and safety of immunotherapy in patients with advanced or recurrent GIST, particularly those who have failed previous TKI therapy, to inform future clinical decision-making and research directions.</div></div><div><h3>Methods</h3><div>A systematic literature search of PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov was conducted for studies published before June 23, 2025. The inclusion criteria focused on immunotherapy interventions in patients with histologically confirmed GIST. Study selection, data extraction, and risk of bias assessments were performed independently by 2 reviewers according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Joanna Briggs Institute checklist was used for quality appraisal. Random-effects models were used to pool estimates of clinical benefit rate (CBR), objective response rate (ORR), progression-free survival (PFS), and overall survival (OS). Generalized linear mixed models (GLMM) were used to account for cohorts with extreme values. This review protocol was registered with the International Registry of Systematic Reviews (registration number: CRD42024496866).</div></div><div><h3>Results</h3><div>A total of 9 studies involving 169 patients were included. The pooled CBR was 41.69% (95% CI, 26.99%–58.03%), and the ORR was 16.49% (95% CI, 6.25%–36.91%), both with moderate to high heterogeneity. GLMM adjustments, which incorporated additional extreme value cohorts, yielded a corrected CBR of 46.39% (95% CI, 28.85%–64.88%) and ORR of 13.23% (95% CI, 4.21%–34.56%). The pooled median PFS across 7 cohorts was 6.11 months (95% CI, 2.63–9.59), and the OS, which was calculated using 2 models, ranged from 15.53 to 17.01 months, depending on the data imputation strategy.</div></div><div><h3>Conclusion</h3><div>This meta-analysis suggests that immunotherapy provides modest yet clinically meaningful efficacy in patients with advanced or treatment-refractory GIST. Despite considerable heterogeneity among studies, the observed trends in response and survival outcomes support immunotherapy as a viable treatment option. Further large-scale, biomarker-driven clinical trials are warranted to validate these findings and guide personalized therapeutic strategies.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 3","pages":"Article 102307"},"PeriodicalIF":2.4,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysphagia megalatriensis as differential diagnosis of recurrence in a long-term survivor of gastric cancer: an uncommon cause of dysphagia beyond the alimentary tract 巨噬性吞咽困难作为胃癌长期存活患者复发的鉴别诊断:消化道以外的一种罕见的吞咽困难病因。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-16 DOI: 10.1016/j.gassur.2025.102305
Enrique Biel , Juan Sánchez-Parrilla , Manuel Pera
{"title":"Dysphagia megalatriensis as differential diagnosis of recurrence in a long-term survivor of gastric cancer: an uncommon cause of dysphagia beyond the alimentary tract","authors":"Enrique Biel ,&nbsp;Juan Sánchez-Parrilla ,&nbsp;Manuel Pera","doi":"10.1016/j.gassur.2025.102305","DOIUrl":"10.1016/j.gassur.2025.102305","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102305"},"PeriodicalIF":2.4,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145781039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative endoscopy in revisional bariatric surgery: who should hold the scope? 矫正减肥手术术前内窥镜检查:谁应该握镜?
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.gassur.2025.102303
Sergio Carandina , Salvatore Avallone , Viola Zulian , Francesco Angrisani , Luigi Angrisani , Antonio Iannelli

Background

Preoperative esophagogastroduodenoscopy (EGD) is a key component of revisional bariatric surgery workup. However, the completeness and surgical relevance of reports may vary depending on whether the examination is performed by a gastroenterologist or a bariatric surgeon. This study aimed to compare the diagnostic completeness and surgical relevance of preoperative EGD reports performed by gastroenterologists with that performed by bariatric surgeons in candidates for revisional bariatric surgery.

Methods

This was a retrospective study that reviewed 88 patients who underwent revisional bariatric surgery after sleeve gastrectomy (SG) or gastric bypass (GB) between January 2024 and April 2025 in 2 bariatric centers in France. Patients were divided into 2 groups: group G (endoscopy by gastroenterologists [n = 44]) and group S (endoscopy by bariatric surgeons [n = 44]). Each report was evaluated using a standardized checklist of surgery-relevant items. The primary endpoint was the Completeness Index (CoI; percentage of mandatory items documented). The secondary endpoints included use of objective measurements, classification of sleeve dilation, documentation of bile reflux, and structured reporting.

Results

In the SG subgroup (n = 48), reports by surgeons achieved higher CI scores than those of gastroenterologists (93.5% ± 10.3% vs 69.6% ± 10.6%, respectively; P <.0001). Sleeve dilation classification and bile reflux were consistently documented by surgeons but rarely by gastroenterologists. In the GB subgroup (n = 40), surgeon-performed reports also showed greater completeness than gastroenterologist-performed reports (88.7% ± 11.4% vs 41.2% ± 9.1%, respectively; P <.0001), with more frequent documentation of pouch size, anastomosis diameter, and configuration. Both groups described anatomical landmarks, such as the esophagogastric junction, comparably.

Conclusion

Surgeon-performed EGD provides more complete, surgery-oriented information than gastroenterologist-performed examinations, particularly regarding sleeve morphology, pouch size, and anastomotic configuration. Structured reporting and collaboration are essential for optimizing preoperative evaluation in revisional bariatric surgery.
背景:术前食管胃十二指肠镜检查(EGD)是矫正减肥手术检查的关键组成部分。然而,报告的完整性和外科相关性可能会因检查是由胃肠病学家还是减肥外科医生进行而有所不同。目的:比较胃肠病学家和减肥外科医生对改进性减肥手术患者术前EGD报告的诊断完整性和手术相关性。背景:法国的两个减肥中心。方法:我们回顾性分析了2024年1月至2025年4月期间88例在套管胃切除术(SG)或胃旁路手术(GB)后接受矫正性减肥手术的患者。患者分为两组:G组(胃肠内科医生内镜检查,n=44)和S组(减肥外科医生内镜检查,n=44)。每个报告都用标准化的手术相关项目清单进行评估。主要终点是完整性指数(记录的强制性项目的百分比)。次要终点包括使用客观测量、套筒扩张分类、胆汁反流记录和结构化报告。结果:在SG亚组(n=48)中,外科医生报告的完整性指数得分高于胃肠病学医生(93.5±10.3% vs 69.6±10.6%)。结论:外科医生进行的EGD比胃肠病学医生进行的检查提供了更完整的、以手术为导向的信息,特别是在套状形态、袋大小和吻合口结构方面。结构化的报告和协作对于优化改良减肥手术的术前评估至关重要。
{"title":"Preoperative endoscopy in revisional bariatric surgery: who should hold the scope?","authors":"Sergio Carandina ,&nbsp;Salvatore Avallone ,&nbsp;Viola Zulian ,&nbsp;Francesco Angrisani ,&nbsp;Luigi Angrisani ,&nbsp;Antonio Iannelli","doi":"10.1016/j.gassur.2025.102303","DOIUrl":"10.1016/j.gassur.2025.102303","url":null,"abstract":"<div><h3>Background</h3><div>Preoperative esophagogastroduodenoscopy (EGD) is a key component of revisional bariatric surgery workup. However, the completeness and surgical relevance of reports may vary depending on whether the examination is performed by a gastroenterologist or a bariatric surgeon. This study aimed to compare the diagnostic completeness and surgical relevance of preoperative EGD reports performed by gastroenterologists with that performed by bariatric surgeons in candidates for revisional bariatric surgery.</div></div><div><h3>Methods</h3><div>This was a retrospective study that reviewed 88 patients who underwent revisional bariatric surgery after sleeve gastrectomy (SG) or gastric bypass (GB) between January 2024 and April 2025 in 2 bariatric centers in France. Patients were divided into 2 groups: group G (endoscopy by gastroenterologists [n = 44]) and group S (endoscopy by bariatric surgeons [n = 44]). Each report was evaluated using a standardized checklist of surgery-relevant items. The primary endpoint was the Completeness Index (CoI; percentage of mandatory items documented). The secondary endpoints included use of objective measurements, classification of sleeve dilation, documentation of bile reflux, and structured reporting.</div></div><div><h3>Results</h3><div>In the SG subgroup (n = 48), reports by surgeons achieved higher CI scores than those of gastroenterologists (93.5% ± 10.3% vs 69.6% ± 10.6%, respectively; <em>P</em> &lt;.0001). Sleeve dilation classification and bile reflux were consistently documented by surgeons but rarely by gastroenterologists. In the GB subgroup (n = 40), surgeon-performed reports also showed greater completeness than gastroenterologist-performed reports (88.7% ± 11.4% vs 41.2% ± 9.1%, respectively; <em>P</em> &lt;.0001), with more frequent documentation of pouch size, anastomosis diameter, and configuration. Both groups described anatomical landmarks, such as the esophagogastric junction, comparably.</div></div><div><h3>Conclusion</h3><div>Surgeon-performed EGD provides more complete, surgery-oriented information than gastroenterologist-performed examinations, particularly regarding sleeve morphology, pouch size, and anastomotic configuration. Structured reporting and collaboration are essential for optimizing preoperative evaluation in revisional bariatric surgery.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102303"},"PeriodicalIF":2.4,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145774904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Shouldice renaissance: revisiting tissue repair in the era of mesh-based technique 肩部的复兴:重访组织修复在网格为基础的技术时代。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.gassur.2025.102304
Vipul D. Yagnik , Prema Ram Choudhary , Pankaj Garg
{"title":"The Shouldice renaissance: revisiting tissue repair in the era of mesh-based technique","authors":"Vipul D. Yagnik ,&nbsp;Prema Ram Choudhary ,&nbsp;Pankaj Garg","doi":"10.1016/j.gassur.2025.102304","DOIUrl":"10.1016/j.gassur.2025.102304","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102304"},"PeriodicalIF":2.4,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic right hemihepatectomy for perihilar cholangiocarcinoma (with video) 机器人右半肝切除术治疗肝门周围胆管癌(附视频)。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.gassur.2025.102302
Marcel Autran Machado, Bruno H. Mattos, Murillo Lobo Filho, Fábio Makdissi
{"title":"Robotic right hemihepatectomy for perihilar cholangiocarcinoma (with video)","authors":"Marcel Autran Machado,&nbsp;Bruno H. Mattos,&nbsp;Murillo Lobo Filho,&nbsp;Fábio Makdissi","doi":"10.1016/j.gassur.2025.102302","DOIUrl":"10.1016/j.gassur.2025.102302","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102302"},"PeriodicalIF":2.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Medicaid expansion on treatment and outcomes in patients undergoing surgery for common colorectal conditions 医疗补助扩大对普通结直肠癌手术患者治疗和预后的影响。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.gassur.2025.102300
Mayin Lin , John C. Hsieh , Miya C. Yoshida , Julie S. Hong , Christopher M. Foglia , Steven Y. Chao
{"title":"Impact of Medicaid expansion on treatment and outcomes in patients undergoing surgery for common colorectal conditions","authors":"Mayin Lin ,&nbsp;John C. Hsieh ,&nbsp;Miya C. Yoshida ,&nbsp;Julie S. Hong ,&nbsp;Christopher M. Foglia ,&nbsp;Steven Y. Chao","doi":"10.1016/j.gassur.2025.102300","DOIUrl":"10.1016/j.gassur.2025.102300","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102300"},"PeriodicalIF":2.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors for operative intervention in adult patients with foreign body ingestion 成人异物摄入患者手术干预的预测因素。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.gassur.2025.102297
Shea Gallagher , Cameron Ghafil , Li Ding , Yu-Tung Wu , Edward Compton , Shivani Sundaram , Philip Paulson , Morgan Schellenberg , James Buxbaum , Matthew Martin , Kenji Inaba , Kazuhide Matsushima

Background

The management of foreign body ingestion (FBI) in the adult population varies widely given the lack of evidence-based guidelines. This study aimed to identify risk factors associated with the need for operative intervention in these cases.

Methods

This was a retrospective cohort study between July 2015 and January 2021. All adult patients (age ≥18 years) presenting after FBI were included. We collected and analyzed demographics and clinical outcomes data. Multivariable regression was used to identify foreign body (FB) characteristics associated with operative interventions.

Results

A total of 303 patient encounters were included. Ingested FBs were classified as sharp/pointed (64.7%), blunt (40.6%), magnetic (8.3%), or corrosive/battery (5.0%). Notably, 40% underwent endoscopic interventions, including esophagogastroduodenoscopy (35.3%) and colonoscopy (4.6%). Twelve patients (4.0%) underwent an operative intervention secondary to perforation or failure to progress. Patients with perforation or failure to progress had longer median FB lengths than patients without these complications (11.5 vs 3.0 cm; P <.001). On multivariate regression analysis, FB length was significantly associated with the need for operative intervention (odds ratio [OR], 1.67 for each centimeter increment; P <.001). The ingestion of sharp/pointed objects was associated with a lower risk of operative intervention (OR, 0.20; P =.04).

Conclusion

Adult patients who present after FBI can often be managed conservatively. The length of ingested objects seems to be more associated with the need for operative intervention rather than the shape. Early endoscopic removal of high-risk FBs should be considered when feasible.
背景:由于缺乏循证指南,成年人摄入异物的管理存在很大差异。本研究的目的是确定与这些病例需要手术干预相关的危险因素。方法:这是一项2015年7月至2021年1月的回顾性队列研究。所有摄入异物后出现的成年患者(年龄≥18岁)均纳入研究。我们收集并分析了人口统计学和临床结果数据。使用多变量回归来识别与手术干预相关的异物特征。结果:共纳入303例患者。误食异物分为尖锐类(64.7%)、钝性类(40.6%)、磁性类(8.3%)、腐蚀性类(5.0%)。40%的患者接受了内镜干预,包括食管胃十二指肠镜检查(35.3%)和结肠镜检查(4.6%)。12例(4.0%)患者因穿孔或进展失败而接受手术干预。与没有这些并发症的患者相比,穿孔或进展失败的患者的中位异物长度更长(11.5cm vs. 3.0cm)。结论:摄入异物后出现的成年患者通常可以保守治疗。摄入物体的长度似乎与手术干预的需要有关,而不是形状。在可行的情况下,应考虑早期内镜下切除高危异物。
{"title":"Predictors for operative intervention in adult patients with foreign body ingestion","authors":"Shea Gallagher ,&nbsp;Cameron Ghafil ,&nbsp;Li Ding ,&nbsp;Yu-Tung Wu ,&nbsp;Edward Compton ,&nbsp;Shivani Sundaram ,&nbsp;Philip Paulson ,&nbsp;Morgan Schellenberg ,&nbsp;James Buxbaum ,&nbsp;Matthew Martin ,&nbsp;Kenji Inaba ,&nbsp;Kazuhide Matsushima","doi":"10.1016/j.gassur.2025.102297","DOIUrl":"10.1016/j.gassur.2025.102297","url":null,"abstract":"<div><h3>Background</h3><div>The management of foreign body ingestion (FBI) in the adult population varies widely given the lack of evidence-based guidelines. This study aimed to identify risk factors associated with the need for operative intervention in these cases.</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study between July 2015 and January 2021. All adult patients (age ≥18 years) presenting after FBI were included. We collected and analyzed demographics and clinical outcomes data. Multivariable regression was used to identify foreign body (FB) characteristics associated with operative interventions.</div></div><div><h3>Results</h3><div>A total of 303 patient encounters were included. Ingested FBs were classified as sharp/pointed (64.7%), blunt (40.6%), magnetic (8.3%), or corrosive/battery (5.0%). Notably, 40% underwent endoscopic interventions, including esophagogastroduodenoscopy (35.3%) and colonoscopy (4.6%). Twelve patients (4.0%) underwent an operative intervention secondary to perforation or failure to progress. Patients with perforation or failure to progress had longer median FB lengths than patients without these complications (11.5 vs 3.0 cm; <em>P</em> &lt;.001). On multivariate regression analysis, FB length was significantly associated with the need for operative intervention (odds ratio [OR], 1.67 for each centimeter increment; <em>P</em> &lt;.001). The ingestion of sharp/pointed objects was associated with a lower risk of operative intervention (OR, 0.20; <em>P</em> =.04).</div></div><div><h3>Conclusion</h3><div>Adult patients who present after FBI can often be managed conservatively. The length of ingested objects seems to be more associated with the need for operative intervention rather than the shape. Early endoscopic removal of high-risk FBs should be considered when feasible.</div></div>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102297"},"PeriodicalIF":2.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invited commentary on “Minimally invasive surgery in hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk” 特邀评论:肝细胞癌的微创手术:患者选择和复发风险的演变权衡。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.gassur.2025.102299
Abu Bakar Hafeez Bhatti
{"title":"Invited commentary on “Minimally invasive surgery in hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk”","authors":"Abu Bakar Hafeez Bhatti","doi":"10.1016/j.gassur.2025.102299","DOIUrl":"10.1016/j.gassur.2025.102299","url":null,"abstract":"","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":"30 2","pages":"Article 102299"},"PeriodicalIF":2.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence-driven 3-dimensional simulation system for enhanced preoperative planning in gastric cancer surgery: a retrospective validation study. 人工智能驱动的三维仿真系统增强胃癌手术术前计划:一项回顾性验证研究。
IF 2.4 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-08 DOI: 10.1016/j.gassur.2025.102295
Sachiko Kaida, Yoko Murakami, Yuto Masaki, Yuki Suzuki, Yukihiro Nagatani, Yoshito Otake, Yoshinobu Sato, Shoji Kido, Yoshiyuki Watanabe, Masaji Tani

Background: Few studies have developed artificial intelligence (AI) systems for the automatic recognition of the anatomy of the stomach, a dynamic organ capable of expansion and contraction. This study aimed to create a 3-dimensional (3D) simulation to assist gastric cancer surgery by combining AI models to visualize the positional relationships among the stomach, surrounding organs, and blood vessels.

Methods: A deep learning-based model was developed using an AI system to segment abdominal organs and detect blood vessels, including midartery-level structures, from contrast-enhanced computed tomography (CT) images. Surgical structures, including the stomach, pancreas, and arteries, were extracted using a blood vessel detection model. Of note, 2 surgeons and 2 radiologists evaluated 51 3D images for structural detection confidence using a 5-point scale and compared them to standard CT images.

Results: A retrospective analysis of 51 cases of preoperative patients with gastric cancer demonstrated that AI-generated images provided clear visualization of the spatial relationships between blood vessels and organs. Structures, including the left hepatic-left gastric artery, common duct and its branches, and the short gastric artery distinct from the splenic artery, were clearly identified. These findings were useful for surgical planning. The reliability score for detecting blood vessels was significantly higher (P <.05) for the AI images than for the CT images, with good agreement among the evaluators.

Conclusion: Automatic organ recognition systems are promising, valuable tools for gastric cancer surgery, improving preoperative planning and potentially reducing operative time and complications.

背景:很少有研究开发人工智能系统来自动识别胃的解剖结构,胃是一个能够扩张和收缩的动态器官。本研究旨在通过结合人工智能模型,可视化胃、周围器官和血管之间的位置关系,创建一个三维模拟,以辅助胃癌手术。方法:我们开发了一个基于深度学习的模型,使用人工智能系统来分割腹部器官并检测血管,包括对比增强计算机断层扫描图像中的中动脉水平结构。使用血管检测模型提取包括胃、胰腺和动脉在内的手术结构。两名外科医生和两名放射科医生使用五分制评估了51张三维图像的结构检测置信度,并将其与标准计算机断层扫描图像进行了比较。结果:对51例术前胃癌患者的回顾性分析表明,人工智能生成的图像可以清晰地显示血管和器官之间的空间关系。可见肝-胃左动脉、总管及其分支、与脾动脉不同的胃短动脉等结构。这些发现对手术计划是有用的。与计算机断层扫描图像相比,人工智能图像检测血管的可靠性评分显著高于计算机断层扫描图像(P < 0.05),评价者之间具有良好的一致性。结论:自动器官识别系统在胃癌手术中具有重要的应用价值,可改善术前计划,减少手术时间和并发症。
{"title":"Artificial intelligence-driven 3-dimensional simulation system for enhanced preoperative planning in gastric cancer surgery: a retrospective validation study.","authors":"Sachiko Kaida, Yoko Murakami, Yuto Masaki, Yuki Suzuki, Yukihiro Nagatani, Yoshito Otake, Yoshinobu Sato, Shoji Kido, Yoshiyuki Watanabe, Masaji Tani","doi":"10.1016/j.gassur.2025.102295","DOIUrl":"10.1016/j.gassur.2025.102295","url":null,"abstract":"<p><strong>Background: </strong>Few studies have developed artificial intelligence (AI) systems for the automatic recognition of the anatomy of the stomach, a dynamic organ capable of expansion and contraction. This study aimed to create a 3-dimensional (3D) simulation to assist gastric cancer surgery by combining AI models to visualize the positional relationships among the stomach, surrounding organs, and blood vessels.</p><p><strong>Methods: </strong>A deep learning-based model was developed using an AI system to segment abdominal organs and detect blood vessels, including midartery-level structures, from contrast-enhanced computed tomography (CT) images. Surgical structures, including the stomach, pancreas, and arteries, were extracted using a blood vessel detection model. Of note, 2 surgeons and 2 radiologists evaluated 51 3D images for structural detection confidence using a 5-point scale and compared them to standard CT images.</p><p><strong>Results: </strong>A retrospective analysis of 51 cases of preoperative patients with gastric cancer demonstrated that AI-generated images provided clear visualization of the spatial relationships between blood vessels and organs. Structures, including the left hepatic-left gastric artery, common duct and its branches, and the short gastric artery distinct from the splenic artery, were clearly identified. These findings were useful for surgical planning. The reliability score for detecting blood vessels was significantly higher (P <.05) for the AI images than for the CT images, with good agreement among the evaluators.</p><p><strong>Conclusion: </strong>Automatic organ recognition systems are promising, valuable tools for gastric cancer surgery, improving preoperative planning and potentially reducing operative time and complications.</p>","PeriodicalId":15893,"journal":{"name":"Journal of Gastrointestinal Surgery","volume":" ","pages":"102295"},"PeriodicalIF":2.4,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gastrointestinal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1